Daurismo (Glasdegib)
- Medicine Name: Daurismo
- Generic Name: Glasdegib
- Dosage Form & Strength: Tablets: 100 mg, 25 mg
- Manufactured By: Pfizer Inc.
Daurismo is a hedgehog pathway inhibitor used, in combination with low-dose cytarabine, to treat newly-diagnosed acute myeloid leukemia (AML) in those patients who are aged ≥75 years or have comorbidities that preclude the consideration of intensive induction chemotherapy.
Recommended Dosage: The recommended dose of Daurismo tablets is 100 mg orally once daily on days 1-28 along with medicine cytarabine 20 mg subcutaneously twice daily on days 1-10 of each 28-day cycle in absence of unacceptable toxicity or loss of disease control. For those without unacceptable toxicity, treat for at least six cycles to allow time for clinical response.
Administer this medication with or without food. Do not split or crush the tablets. Administer it about the same time each day. If a dose of Daurismo is vomited, do not take a replacement dose; wait until the next scheduled dose of Daurismo is due. If a dose of Daurismo is missed, take the dose as promptly as possible and at least 12 hours before the very next scheduled dose. Back to the standard Daurismo dosing schedule the following day. Do not administer a couple of doses within 12 hours.
- Evaluate complete blood counts, electrolytes, renal, and hepatic function before initiating therapy with glasdegib 100 mg tablets and at least once weekly for the 1’st month. Assess renal function once monthly throughout the therapy. Obtain serum creatine kinase levels before starting treatment and as indicated clinically thereafter (e.g., if muscle signs/symptoms are reported).
- Patients treated with Daurismo can have QTc prolongation and ventricular arrhythmias, including ventricular tachycardia and ventricular fibrillation. Monitor electrocardiograms (ECGs) and electrolytes. Discontinue DAURISMO 25 mg tablets permanently for patients who have QTc interval prolongation with signs/symptoms of hazardous arrhythmia.
- Daurismo is not for use during pregnancy. The pregnancy testing is required in female patients of reproductive age prior to initiating treatment. Females of reproductive age should use effective contraception throughout the treatment and for at least 30 days after the final dose. Women should not breastfeed throughout therapy with DAURISMO 100 mg tablets and for at least 30 days after the final dose.
- It is not recommended to donate blood or blood products while taking treatment with Glasdegib and for at least 30 days after the final dose of Glasdegib because the blood or blood products might be given to a female of reproductive age or potential.
What documents are required to import DAURISMO to India?
DAURISMO (Glasdegib) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation required to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients Identity Proof (issued by government of India)
How does order be confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is DAURISMO available in India?
DAURISMO (glasdegib tablets) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network (IPN) is facilitator providing input:
- On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
DAURISMO can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
IPN (Indian Pharma Network) can facilitate the supply of DAURISMO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for daurismo price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the DAURISMO (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma Network offers its customers worldwide access to the best available treatment.
Indian Pharma Network (IPN) is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Daurismo®?
Glasdegib is Generic Name for the trade name drug Daurismo®.
What is the Manufacturer Name of Daurismo®?
Daurismo® is manufactured by Pfizer Inc.
Is Daurismo® approved by the FDA?
Yes, Daurismo® is approved by the FDA. Date of first approval: November 21, 2018.
What is the dosage and form of Daurismo® supplied?
Daurismo® is supplied as Tablets: 25 mg & 100 mg for oral administration.
What are the most common side effects with Daurismo®?
Most common side effects with Daurismo® include: rash, anemia, fatigue, edema, hemorrhage, musculoskeletal pain, febrile neutropenia, nausea, decreased appetite, thrombocytopenia, dyspnea, mucositis, dysgeusia, and constipation.
What should I avoid while taking Daurismo®?
Avoid donating blood or blood products throughout the therapy with Daurismo® and for at least 30 days after the final dose. Avoid donating semen throughout the therapy with Daurismo® and for at least 30 days after the final dose.
How much does Daurismo® cost in India?
The daurismo cost in India is reasonable. To procure this AML medication authentically, you can call or WhatsApp +91-9310090915 or dial TOLL-FREE: 1800-889-1064, or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Daurismo®?
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F).
Where can I get Daurismo® at the best price in India?
To get the best daurismo price in India, you can connect with Indian Pharma Network (IPN), or any other legitimate Pharmaceutical Wholesaler Company which is certified by WHO-GDP and ISO 9001:2008. A medical prescription is needed while buying Daurismo®.
Is it safe to buy Daurismo® online from India?
Yes, You can buy Daurismo 25 mg tablets online from India authentically from https://www.indianpharmanetwork.in/ if Daurismo® is not available or has not been approved in your home country.
What are the Highlights of prescribing information for Daurismo®?
Click Here to download full Daurismo prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis. CMV retinitis is kind of an eye infection caused by a virus. CMV mainly attacks the retina of the eye and can be responsible for causing loss of vision, and eventually may lead to the blindness. Patients with acquired immunodeficiency syndrome are more likely to develop CMV retinitis.